The Society of Gynecologic Oncology and ASCCP endorse this document. USPSTF Cervical Cancer Screening Recommendations for Average-Risk. As with the updates, the new ACS/ASCCP/ASCP guidelines suggest a . Comparison of Cervical Cancer Screening Guidelines. Co-testing is preferable to using a Pap test alone for women ages 30– 1 ACS, ASCCP, & ASCP guidelines update In March

Author: Zolorisar Malazuru
Country: Brazil
Language: English (Spanish)
Genre: History
Published (Last): 22 June 2009
Pages: 180
PDF File Size: 20.48 Mb
ePub File Size: 13.55 Mb
ISBN: 742-2-16201-945-6
Downloads: 81621
Price: Free* [*Free Regsitration Required]
Uploader: Dokasa

Discontinue if three negative Pap smear results or two negative HPV test results in past 10 years, if most recent test was within the past five years.

Abnormal vaginal cytology is seldom of clinical importance. Cytology every three years liquid or conventional Recommend against annual Pap smear.

Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Women who have undergone hysterectomy. This information is designed as an educational resource to aid guideliines in providing ppa and gynecologic care, and use of this information is voluntary.

Agency for Healthcare Research and Quality; Discontinue if hysterectomy for benign reason. The potential harm outweighs the small potential benefit of screening women in this age group.

Therefore, these women should not be referred directly for colposcopy.

Practice Advisory: Cervical Cancer Screening (Update) – ACOG

Because the KPNC follow up of patients covers less than 10 years, more time will be needed to see if these women can return to routine screening after multiple negative follow-up tests. Reprints are not available from the authors.

A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. Cervical Cancer Screening Update.


Address correspondence to Patricia L. The biggest gain in reducing cervical cancer incidence and mortality can be achieved by increasing screening rates among women who have not been screened or who have not been screened regularly.

Guidelines – ASCCP

There is no statistically significant difference in cancer reduction between a two- and three-year screening interval, and the shorter two-year screening interval results in a 40 percent increase in the number of colposcopies.

Choose a single article, issue, or full-access subscription. Colposcopy is also recommended when two consecutive Paps are unsatisfactory.

Screening is no longer recommended for adolescents. While their use is not required, clinicians electing to use genotyping need guidance on when to use and how to interpret these tests and how results affect management. How do I manage my patients? Screening for cervical cancer: Managing women with unsatisfactory cytology and specimens missing endocervical or transformation zone components Category: Like the USPSTF recommendations, these expert guidelines recognize that cytology alone, hrHPV testing alone, and co-testing are all effective screening strategies for average-risk women aged 30—65 years.

The guidelines are based on a systematic evidence review. Women with no CIN2,3 at colposcopy should be observed with colposcopy and cytology every 6 months for up to two years, until 2 consecutive negative Pap tests are reported and no high-grade colposcopic abnormality is observed.

A Practice Advisory is issued when information on an emergent clinical issue e.

Updated Consensus Guidelines FAQs

Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. How is management modified in women years of age? Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.


No relevant financial affiliations to disclose.

Am J Clin Pathol. However, expert guidelines recommend that for these women, co-testing with cervical cytology and hrHPV testing every 5 years is preferred, screening with cervical cytology alone every 3 years guidelunes acceptable, and hrHPV testing alone can be considered as an alternative screening strategy 4.

Co-testing with cytology and HPV testing every five years preferred or every three years with cytology alone acceptable.


Co-testing with cytology and HPV testing every five years or every three years with cytology alone. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines guieelines the prevention and early detection of cervical cancer.

See My Guidelinew close. A Practice Advisory is a brief, focused statement issued within hours of the release of this evolving information and constitutes ACOG clinical guidance. For women 21 to 29 years of age, the new guidelines recommend screening with cytology alone every three years. This suggests that less aggressive assessment will minimize potential harms of managing abnormalities likely to resolve spontaneously.